5 recruiting, 1 completed, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Ampullary Adenocarcinoma: new trials by email Literature Review of Ampullary Adenocarcinoma trials Research Report on Ampullary Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma Hepatic Artery Infusion Pump (HAIP), Floxuridine (FUDR) - Pancreas Cancer With Hepatic Metastase, Pancreas Adenocarcinoma | Recruiting | AdventHealth | 10 | 2026-11-01 | 2026-09-29 | |
| Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels Sequential cytoreductive intervention, Signatera Genome ultra-sensitive ctDNA blood test - Foregut Adenocarcinoma, Esophageal Adenocarcinoma | Phase 2 | Recruiting | Yale University | 54 | 2026-06-02 | 2026-09-08 |
| PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma mFOLFORINOX, Capecitabine or gemcitabine, Quality of life questionnaires: QLQ-C30 and PAN26 - Ampullary Adenocarcinoma | Phase 3 | Recruiting | Centre Hospitalier Universitaire Dijon | 294 | 2025-07-02 | 2025-07-11 |
| The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. Folfirinox, Capox - Ampullary Adenocarcinoma | Recruiting | Fondazione Poliambulanza Istituto Ospedaliero | 400 | 2023-07-01 | 2023-10-05 | |
| Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula total pancreatectomy, intraportal islet autotransplantation - Adenocarcinoma of the Pancreas, Adenocarcinoma of the Duodenum | Phase 1 / Phase 2 | Recruiting | University Hospital, Lille | 36 | 2022-02-20 | 2025-09-25 |
| Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors Robotic pancreaticoduodenectomy, Open pancreaticoduodenectomy - Pancreatic Adenocarcinoma, Pancreatic Cysts | Not applicable | Completed | Ruijin Hospital | 268 | 2020-09-28 | 2025-12-18 |
| Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma treatment for ampullary adenocarcinoma - Ampullary Adenocarcinoma | Unknown | Federation Francophone de Cancerologie Digestive | 402 | 2017-07-07 | 2022-03-24 |
Cholangiocarcinoma (2) · Pancreatic Neoplasms (2) · Adenocarcinoma (1) · Adenocarcinoma Of Esophagus (1) · Duodenal Neoplasms (1) · Pancreatic Cyst (1) · Pancreatitis, Chronic (1) · Recurrence (1)
Neoplasms (4) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Adenocarcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplasms by Site (2) · Pancreatic Diseases (2) · Chronic Disease (1) · Cysts (1) · Disease Attributes (1) · Duodenal Diseases (1)
Capecitabine (2) · Floxuridine (1) · Fluorouracil (1) · Gemcitabine (1) · Irinotecan (1) · Leucovorin (1) · Oxaliplatin (1) · Therapeutics (1) · folfirinox (1)
AdventHealth (1) · Centre Hospitalier Universitaire Dijon (1) · Federation Francophone de Cancerologie Digestive (1) · Fondazione Poliambulanza Istituto Ospedaliero (1) · Ruijin Hospital (1) · University Hospital, Lille (1) · Yale University (1)
France (3) · United States (2) · China (1) · Italy (1)
Baiyong Shen, PhD (1) · Kiran Turaga, MD (1) · Moh'd Abu Hilal, MD, PhD (1)